PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
18-Jul-2023 Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance Businesswire
18-Jul-2023 Harrow Announces Proposed Public Offering of Common Stock Businesswire
18-Jul-2023 Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq Businesswire
18-Jul-2023 Leading Food-and-Drug Lawyer John Fuson Joins Kleinfeld Kaplan & Becker LLP as Partner Businesswire
18-Jul-2023 Qihan Biotech Announces NMPA Approval of Investigational New Drug (IND) Application for QN-019a, a Multi-locus Gene-Editing Cell Therapy Product to treat CD19-positive B-Cell Lymphoma Businesswire
18-Jul-2023 ADOCIA confirms its eligibility for the PEA–PME Businesswire
18-Jul-2023 VitalConnect Secures over $30 Million in Oversubscribed Series F Financing Businesswire
18-Jul-2023 Global Cancer Vaccine Market, Vaccine Price, Dosage, Sales & Clinical Trials Outlook Report 2023-2029 - ResearchAndMarkets.com Businesswire
18-Jul-2023 Oxford Finance’s Healthcare Leveraged Lending Group Provides 2023 Mid-Year Update Businesswire
18-Jul-2023 MEI Pharma Responds to Anson and Cable Car Businesswire
18-Jul-2023 2023 Data Exposure Report: Life Sciences Sector Prioritizes Insider Risk Management Amid Increasing Data Loss Incidents Businesswire
18-Jul-2023 AdaCore Announces GNAT Pro for Rust Businesswire
18-Jul-2023 ENB Therapeutics Presents Top-line Results from Phase 1b ENBOLDEN-101 Study in Solid Tumors Refractory to Standard of Care at the Immuno-oncology Summit 2023 Businesswire
18-Jul-2023 AdaptHealth Corp. Announces Second Quarter 2023 Earnings Release Date and Conference Call Businesswire
18-Jul-2023 Engrail Therapeutics Initiates the ENCALM Phase 2 Clinical Trial of ENX-102 in Patients with Generalized Anxiety Disorder Businesswire
18-Jul-2023 2023 Dangerous Goods Symposium to Examine Hazmat Shipping Issues Businesswire
18-Jul-2023 Massive Bio and CureMatch Announce Groundbreaking Partnership to Revolutionize Cancer Treatment through AI and Clinical Trial Accessibility Businesswire
18-Jul-2023 Gain In-Depth Understanding of Process Validation and Phases 1, 2, and 3 Integration at this Interactive Seminar - ResearchAndMarkets.com Businesswire
18-Jul-2023 Global Isolator Market Analysis Report 2023-2028: Digital Isolators and Automation Inside Isolators Transforming the Market, Offering Enhanced Performance and Reliability - ResearchAndMarkets.com Businesswire
18-Jul-2023 Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares Businesswire